|
Mar '05 |
Mar '06 |
Mar '07 |
Mar '08 |
Mar '09 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Net Profit Before Tax |
188.51 |
160.87 |
171.05 |
513.95 |
114.46 |
| Net Cash From Operating Activities |
155.31 |
40.32 |
113.94 |
264.72 |
115.99 |
Net Cash (used in)/from
Investing Activities |
-468.01 |
-48.30 |
-86.77 |
-266.16 |
-74.63 |
| Net Cash (used in)/from Financing Activities |
-1.84 |
4.74 |
-24.44 |
6.61 |
-43.44 |
| Net (decrease)/increase In Cash and Cash Equivalents |
-314.54 |
-3.25 |
2.72 |
5.17 |
-2.08 |
| Opening Cash & Cash Equivalents |
317.96 |
5.18 |
4.81 |
7.53 |
8.12 |
| Closing Cash & Cash Equivalents |
3.42 |
1.93 |
7.53 |
12.70 |
6.04 |
|
|
|
|
| Source : Religare Technova |
| Explore Biocon connections |
|
